Characteristics | Control group (n = 108) | Restenosis group (n = 117) | p-value |
---|---|---|---|
Age (years) | 66.4 (+−10.8) | 65.7 (+−9.9) | 0.632 |
Gender, male (%) | 83 (76.9%) | 83 (70.9%) | 0.314 |
Anti-hypertensive therapy (%) | 104 (96.3%) | 108 (92.23%) | 0.200 |
Lipid-lowering therapy (%) | 98 (90.7%) | 107 (91.5%) | 0.851 |
Diabetes mellitus (%) | 39 (36.1%) | 39 (33.3%) | 0.662 |
Obesity - BMI > 25 (%) | 76 (70.4%) | 91 (78.4%) | 0.165 |
Smoking | 32 (47.1%) | 36 (52.9%) | 0.927 |
Multi-vessel disease (%) | 10 (9.4%) | 19 (16.2%) | 0.131 |
Acute coronary disease (%) | 61 (57%) | 67 (57.3%) | 0.969 |
Follow up time (years) | 2.73 (+−2.54) | 1.03 (+−1.38) | <0.001 |
Total number of stents | 1.37 (+−0.54) | 1.69 (1.04) | 0.005 |